Company news

HeartSciences Inc. news in 2025

HeartSciences Inc.'s news releases, calls and decks from 2025, newest first.

View company

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

December 15, 2025

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

December 15, 2025

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

December 11, 2025

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

September 11, 2025

HeartSciences Announces Conference Participation and Investor Webinar

August 15, 2025

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

July 24, 2025

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

June 4, 2025

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value

June 3, 2025

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29, 2025

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 20, 2025

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 8, 2025

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 7, 2025

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

May 1, 2025

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

March 13, 2025

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

March 10, 2025